Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia

Biol Blood Marrow Transplant. 2005 Oct;11(10):814-5. doi: 10.1016/j.bbmt.2005.05.016.
No abstract available

Publication types

  • Comparative Study
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Bone Marrow Transplantation / adverse effects
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Graft vs Host Disease / drug therapy
  • Graft vs Host Disease / mortality
  • Graft vs Host Disease / prevention & control*
  • Histocompatibility Testing
  • Humans
  • Leukemia / complications
  • Leukemia / therapy
  • Methotrexate / therapeutic use*
  • Premedication
  • Prevalence
  • Survival Analysis

Substances

  • Cyclosporine
  • Methotrexate